Beckman Coulter DxI 9000 Access Immunoassay Analyzer, catalog number C11137; in-vitro diagnostic ...

FDA Device Recall #Z-1115-2025 — Class II — January 3, 2024

Recall Summary

Recall Number Z-1115-2025
Classification Class II — Moderate risk
Date Initiated January 3, 2024
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Beckman Coulter, Inc.
Location Chaska, MN
Product Type Devices
Quantity 61 units

Product Description

Beckman Coulter DxI 9000 Access Immunoassay Analyzer, catalog number C11137; in-vitro diagnostic instrument

Reason for Recall

A software error caused an increase in tray gripper motion errors that causes intermittent hard stops and a delay in patient results.

Distribution Pattern

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Brazil, Croatia, France, Germany, Hungary, India, Ireland, Italy, New Zealand, Portugal, Slovakia, Spain, Switzerland, Taiwan, Province of China, United Kingdom of Great Britain and Northern Ireland.

Lot / Code Information

UDI/DI 15099590732103, serial numbers: 300208, 300201, 300184, 300185, 300169, 300225, 300175, 300172, 300221, 300209, 300211, 300212, 300213, 300214, 300215, 300210, 300174, 300226, 300204, 300216, 300217, 300170, 300220, 300176, 300188, 300199, 300200, 300177, 300222, 300224, 300173, 300181, 300202, 300191, 300223, 300171, 300186, 300190, 300203, 300178, 300195, 300189, 300198, 300227, 300228, 300168, 300194, 300205, 300206, 300207, 300197, 300218, 300179, 300182, 300192, 300219, 300193, 300183, 300180, 300187, 300196.

Other Recalls from Beckman Coulter, Inc.

Recall # Classification Product Date
Z-1235-2026 Class II CellMek SPS Sample Preparation System, REF: C44... Dec 23, 2025
Z-1025-2026 Class II Beckman Coulter UniCel Dxl 600, Part numbers: ... Nov 26, 2025
Z-1026-2026 Class II Beckman Coulter UniCel Dxl 800, Part numbers: ... Nov 26, 2025
Z-1221-2026 Class II COULTER DxH Diluent, REF 628017 COULTER DxH EC... Nov 10, 2025
Z-0889-2026 Class II Access 2 Reaction Vessels, individual, disposab... Nov 7, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.